DLB
DOLBY LABORATORIES INC-CL A
Latest close $60.64 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | May 31, 2026 observed Jun 4, 2026 filed · 4d Schedule 13G amendment | Earliest Schedule 13G amendment found | 6.0M | 12.00% | $55.81 | $54.04 | $60.64 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 5.8M | $60.64 | |||
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 24, 2024 filed · 24d Schedule 13G amendment | Earliest Schedule 13G amendment found | 5.8M | 9.80% | $60.64 |